A screening method for 18 frequently measured exogenous anabolic steroids and the testosterone/epitestosterone (T/E) ratio in forensic cases has been developed and validated. The method involves a fully automated sample preparation including enzyme treatment, addition of internal standards and solid phase extraction followed by analysis by liquid chromatography -tandem mass spectrometry (LC -MS-MS) using electrospray ionization with adduct formation for two compounds. Urine samples from 580 forensic cases were analyzed to determine the T/E ratio and occurrence of exogenous anabolic steroids. Extraction recoveries ranged from 77 to 95%, matrix effects from 48 to 78%, overall process efficiencies from 40 to 54% and the lower limit of identification ranged from 2 to 40 ng/mL. In the 580 urine samples analyzed from routine forensic cases, 17 (2.9%) were found positive for one or more anabolic steroids. Only seven different steroids including testosterone were found in the material, suggesting that only a small number of common steroids are likely to occur in a forensic context. The steroids were often in high concentrations (>100 ng/mL), and a combination of steroids and/or other drugs of abuse were seen in the majority of cases. The method presented serves as a fast and automated screening procedure, proving the suitability of LC-MS-MS for analyzing anabolic steroids.
Introduction
Anabolic androgenic steroids (AAS) are compounds that mimic the structure and biological effects of the naturally occurring male sex hormone testosterone (T). They are commonly used among certain groups, especially young males striving for a greater muscle mass. Up to 4 million people are currently using AAS (1), even though they are associated with well-known adverse effects (2) .
Testing for AAS in sports was introduced at the Olympic Games in 1976 in Montreal using a radioimmunoassay analysis. This technique was subsequently replaced by gas chromatography (tandem) mass spectrometry (GC-MS-MS) and later by liquid chromatography -tandem mass spectrometry (LC -MS-MS). The common approach among the World Anti-Doping Agency (WADA) laboratories is an enzymatic hydrolysis, followed by liquid-liquid extraction, and finally GC-MS(/MS) or LC-MS-MS analysis (3) . Trimethylsilyl derivatization has proven to greatly improve the sensitivity of GC -MS assays (4) . A major topic in the analysis of AAS is the detection of externally administered T. In the 1980s, an upper limit of 6.0 was set for the ratio between T and epitestosterone (E) (5) , and WADA later lowered the threshold to the current 4.0 limit. However, due to large variations in naturally occurring levels of T, this ratio can exceed 6.0 in some cases (6) . Therefore, a subsequent analysis by GC/ C/IRMS is needed to confirm the presence of pharmaceutically produced T (7) . Newer studies include more endogenous compounds for a complete steroid profile (8 -10) .
The number of published LC -MS methods for screening for AAS has steadily increased over the last decade. A challenge when using LC -MS-MS is the lack of ionization of some compounds. Atmospheric pressure photo ionization, atmospheric pressure chemical ionization and electrospray ionization (ESI) have all been used in the analysis of AAS. An early comparison between the three ionization sources suggested that ESI was the best technique (11) although the chemical properties of the analytes should determine the choice of the source of ionization (12) . Formation of adducts has been applied to compounds that ionize poorly, thereby facilitating the use of LC -ESI -MS-MS analysis in the detection of AAS (13) (14) (15) . Several manual and semi-automated online sample preparation procedures using solid phase extraction (SPE) have been developed for analyzing AAS in human, horse and bovine urine samples (16 -19) .
Findings of AAS in police cases in Sweden from 1999 to 2009 showed that the mean concentrations of the investigated AAS ranged from 135 to 2,080 ng/mL (n ¼ 6,362) with a maximum concentration in a single sample over 30,000 ng/mL (19-norandrosterone) (20) . A high rate of positive samples was seen (33.5%), but this was due to the fact that samples only were analyzed for AAS when police suspected an abuse. The most frequent motive for using AAS concerns the anabolic effects, including the aspect of obtaining a better looking body and performing better in sports (21) . Among other self-reported motives is the desire to become more aggressive or brave, often in a criminal context. A combination of AAS and other drugs of abuse is often seen, as drug addicts use AAS in the belief that they counteract the negative effects of their drug abuse, and abusers motivated by the anabolic effects apply stimulants to train harder (22) .
The method presented here is designed for a forensic laboratory primarily relying on LC-MS equipment. Exogenous compounds were selected on the basis of the findings in the other Nordic countries (20) and from police seizures presented to our laboratory. Because high concentrations of AAS are expected, a fast and efficient automated screening method with high selectivity was prioritized, rather than a more laborious method aiming at fulfilling the sensitivity demands required for doping in sports analysis.
The method presented here provides a fully automated sample preparation followed by LC-MS-MS analysis for common exogenous AAS and their metabolites and also a determination of the T/E ratio. The method presented by Pozo et al. (15) proved that LC -MS using ESI and adduct formation could be used as a qualitative screening tool for exogenous steroids. Automated SPE sample preparation was incorporated into this method, which was further modified to accommodate the analytes of interest. A full qualitative validation for the screening of 18 exogenous AAS including a determination of the lower limit of identification (LLOI) was performed. For determination of the T/E ratio, we compared the concentration ratio determined by using stable isotope-labeled internal standards (SIL-IS) of T and E with a simpler approach using only the peak areas of T and E. The method was used in the analysis of 580 urine samples received from the jurisdiction of Eastern Denmark. Samples from both males and females were collected in a continuous time period to establish the occurrence as well as concentration levels of AAS in a forensic routine material.
Materials and methods
Chemicals Nandrolone (ND) was purchased from Organon (Oss, the Netherlands). 19-Norandrosterone (19NAN), and oxandrolone (OXA) were obtained from Steraloids (Newport, RI, USA). Stanozolol (STAN), methandrostenolone (MD), methyltestosterone (MT) and epitestosterone (E) were from Sigma-Aldrich (St Louis, MO, USA). 3 0 -Hydroxystanozolol (3STAN) and dihydroboldenone (BOLDm) were from LGC Standards (Teddington, UK). 16b-Hydroxystanozolol (16STAN) and methenolone (MET) were from Cerilliant (Austin, TX, USA). Boldenone (BOLD), 17-epimethyltestosterone (17MT), drostanolone (DROS), trenbolone (TREN) and 17-epitrenbolone (17TREN) were from Toronto Research Chemicals (Toronto, Canada). Mesterolone (MEST) and testosterone (T) were purchased from Schering Plough (Levallois Perret Cedex, France). 3a-Hydroxy-1a-methyl-5a-androstane-17-one (MESTm), testosterone-d3 (T-d3) and epitestosterone-d3 (E-d3) were from NMI (Sydney, Australia). Methanol, 2-propanol and water (LC -MS grade) were obtained from Fisher Scientific (Leicestershire, UK). Ammonium acetate was from Merck (Darmstadt, Germany). b-Glucuronidase/arylsulfatase from Helix pomatia was obtained from Roche Diagnostics GmbH (Mannheim, Germany).
Sample preparation
The sample preparation procedure was based on automated SPE using a previously described setup using a Freedom Evo 200 liquid handling robot (Tecan, Ma¨nnerdorf, Switzerland) equipped with several add-ons (23) . All samples and solvents for the glucuronidase treatment were placed in the robot, and 400 mL of urine was transferred from a primary tube to a 96-well plate. The identities of the samples were confirmed using the barcode reader. Diluted glucuronidase enzyme (20 mL, 1:4 enzyme -water, b-glucuronidase activity: 1.65 U, arylsulfatase activity: 5.13 U) was added to each sample followed by ammonium acetate buffer (200 mL, 0.1 M, pH 5.3). Samples were shaken and incubated overnight on the orbital shaker.
After incubation at 408C, the remaining solvents were placed in the robot, and ammonium acetate buffer (400 mL, 1 M, pH 4.0) was added to each sample tube and mixed thoroughly. An aliquot (900 mL) of each sample was transferred to a 96-well plate, and 20 mL of internal standard (176 ng/mL T-d3 and 176 ng/mL E-d3) was added to each sample. The samples were centrifuged and were extracted by reverse-phase SPE using a Strata-X plate (30 mg/well; Phenomenex, Torrance, CA, USA) using water (900 mL) and 40:60 water -methanol (900 mL) as washing solvents and isopropanol -methanol (1:1, 2 Â 300 mL) for elution. After evaporation and reconstitution (60 mL 35:65 methanol-water), samples were transferred and sealed in a new 96-well plate ready for injection on the analytical instrument.
LC-MS-MS analysis
Samples were analyzed by HPLC (1100 series; Agilent, Wilmington, DE, USA) with an upgraded autosampler (1260 series; Agilent, Wilmington, Germany) coupled to the triple quadrupole mass spectrometer (Micromass; Waters, Milford, MA, USA). Separation was performed on a C18 Kinetex column (50 Â 2.10 mm, particle size 2.6 mm; Phenomenex) with aqueous ammonium acetate (1 mM) and methanolic ammonium acetate (1 mM) as mobile phase. The flow rate of the mobile phase was 0.50 mL/min and a gradient varying the percentage of organic solvent linearly: 0 min, 35%; 7 min, 40%; 10 min, 50%; 18.5 min, 60%; 18.5 min, 100%; 20.5 min, 100%; 20.5 min, 35% and 23 min, 35%. The injection volume was 30 mL. The source temperature of the mass spectrometer was held at 1208C and the desolvation temperature at 3008C. Compound-specific settings used for the ionization and fragmentation of analytes are listed in Table I , along with the selected precursor and product ions. Method validation Validation was performed following the guidelines of Eurachem for qualitative analysis (24) . Twenty samples were used to determine the LLOI of the 18 exogenous steroids and to confirm the selectivity of the applied method. The 20 samples were fortified at various concentrations ranging from 2 to 80 ng/mL and included samples from both males and females as well as samples from living and postmortem cases. Identification criteria when using LC -MS-MS were adapted from Rivier (25) , which specifies that the S/N ratio should be above 3; the retention time should differ by ,2% from a reference standard and the relative ion intensity should be within +20% to +50% that of the reference standard depending on the relative abundance of the measured ion to the base peak. The method validation hereby also complied with the Scientific Working Group for Forensic Toxicology (SWGTOX) recommendations in which experiments for interference (minimum 10 sources of sample matrix), testing of carryover and LLOD are required for a qualitative method (26) . Matrix effects (ME), extraction recovery (ER) and process efficiency (PE) were tested by spiking both urine samples and water samples before extraction, after extraction and after evaporation following the procedure suggested by Matuszewski et al. (27) . ME was calculated as ME (%) ¼ B/A Â 100, ER (%) ¼ C/B Â 100 and PE (%) ¼ C/A Â 100, where A corresponds to the area of the peak obtained from a neat standard, B is the area of the peak from a sample spiked after extraction and C corresponds to the area of the peak from a sample spiked before extraction. Sets of eight replicates were used to assess ME, ER and PE. Furthermore, carryover and both short-and long-term stabilities were tested to complete the validation. Ion suppression was further investigated by post-column infusion. When screening the forensic cases for exogenous AAS, a semi-quantitative assessment was applied using calibration points in two replicates at three levels at 5, 20 and 80 ng/mL. The method was not validated as a quantitative method, but this semi-quantitative approach was used to display approximate concentrations in the forensic material. Quality control samples at three levels containing all analytes were included in each batch to validate long-term stability and precision.
T and E were validated for quantitative analysis using T-d3 and E-d3 as internal standards. Linearity was validated by spiking water samples at seven different levels with six replicates over 2 days. Validation of precision and accuracy was performed by spiking urine samples at six levels with eight replicates, thus determining the lower limit of quantification. Baseline concentrations of T and E were determined for each urine sample, and the spiked levels were adjusted accordingly. ME, ER and PE were tested by the procedure described for the qualitative validation of the exogenous AAS.
The determination of the T/E ratio by two different approaches was compared for 45 randomly selected samples from the forensic material, including postmortem samples: † A simple method only using the area of the chromatographic peak of the analyte: T/E ratio (area) ¼ area (T)/area (ET). † A method that used the response of the analyte as corrected by the area of the internal standard multiplied by the concentration (C) of the internal standard:
d3). This method thereby calculated the T/E ratio (SIL-IS) ¼ response (T)/response (ET).

Results
Automated sample preparation
All operations during the SPE sample preparation were automated. Sample preparation was performed in ,3 h, not including the enzyme treatment and incubation of the samples that was performed overnight. Manual interactions were limited to the initial loading of samples, solvents, plates and standards and transferal of the 96-well plate to the analytical instrument. The initial loading process of samples, etc., was performed in ,30 min, and additional time spent on manual labor was minimal. Standard solutions for calibrators, standard addition experiments and SIL-IS were dispensed by the automated liquid handler with an imprecision and bias of ,3%. The pipetting procedure and performance of the automated system have been previously published (23) . The ER ranged from 77 to 95% for all of the compounds (Table II) . The ME was between 48 and 78% yielding an overall PE of 40-54%. (14) .
Retention times were consistent, and the S/N ratio exceeded three in all samples for all compounds. For a few samples, the ion ratio criteria could not be met at low levels for some compounds due to severe ME. These levels were therefore excluded from the identification range. This confirmed that at least 20 different samples should be used for the validation as suggested by Dadgar and Burnett (28) and Peters et al. (29) . The LLOI was established by fulfillment of all identification criteria for all of the 20 fortified samples (Table II) . The LLOI ranged from 2 to 40 ng/mL with 8 of the 18 analytes having a LLOI at 2 ng/mL. Quality control samples in each batch verified long-term stability at levels !LLOI. This proved valid for all analytes including analytes where adduct precursor ions were used.
Quantitative validation of T and E and comparison of methods for determination of T/E ratio
A linear calibration model with R 2 . 0.99 was applied for both T and E with a linear range from 2 to 160 ng/mL for both compounds. MEs were 60 and 64% for T and E, respectively, and ERs were 88 and 84%. The PE was 52% for T and 54% for E, which was considered acceptable and within the same range as for the exogenous AAS. Precision and accuracy were determined by spiking a human urine sample at six levels over the linear range and analyzing each level in replicates of six over 2 days. Accuracy ranged from 93 to 111%, and the overall coefficient of variation (CV) ranged from 2 to 9%.
The two approaches for determining the T/E ratio listed in 'Method validation' were compared by a paired Student's t-test. Logarithmic data transformation was applied due to the larger differences between methods at higher levels of the T/E ratio. The comparison indicated that the method using SIL-IS yielded a T/E ratio that was 16 -22% higher than the measurement based on only the peak areas (95% confidence limits, n ¼ 45, P , 0.0001) (Figure 1 ).
Findings in the forensic material
A total of 580 consecutive urine samples from forensic cases were analyzed including 300 postmortem samples (247 male, 53 female) and 280 samples from living subjects (166 male, 114 female). The ethnicity of the subjects was primarily Caucasian. Postmortem cases included autopsies of drug addicts with supposed poisoning as cause of death, suspicious deaths and fire-related deaths. Samples from antemortem cases included cases of violence, driving under the influence of drugs and cases of sexual assault (both samples from suspects and victims). T/E ratios were determined for all cases and are presented in Table III . The limit for an elevated T/E ratio was set to 6.0 as a more conservative approach compared the current limit of 4.0 set by WADA. A limit at 4.0 would strongly increase the number of false-positive samples, which would need to be further analyzed. Eleven samples (all female) were discarded as the concentration of E was below the limit of quantification, and therefore, the T/E could not be determined. The observed values of T/E ranged from 0.1 to 260 (median value: 1.3; mean value: 2.8).
The median values of the T/E ratios are in accordance with other studies of Caucasian populations (8) , whereas the mean values are slightly higher due to the presence of very high T/E ratios in samples from abusers of T. Seventeen samples were found positive for AAS abuse (Table IV) . Exogenous AAS and/or their metabolites were found in 15 samples, whereas 12 samples had an elevated T/E ratio ranging from 14.5 to 260 (median value: 30.9; mean value: 59.7). Eight additional samples had a slightly elevated T/E ratio above 6 (T/E: 6.4 -8.1; all male samples), but they were not registered as positive samples. These samples needed additional investigations by GC-IR-MS to confirm whether the elevated ratio originated from abuse of T.
All positive samples were from male subjects between the age of 18 and 40 years. Of 13 (46%) antemortem samples, six were directly linked to an act of violence, three (23%) were from suspected sex offenders and the remaining four samples were from other types of cases. Drugs of abuse were found in 11 of the 17 positive samples (65%). The compounds included tetrahydrocannabinol, amphetamine, morphine, 3,4-methylenedioxy-N-methylamphetamine (MDMA), benzodiazepines and ethanol (Table IV) . Two cases are more closely described below as examples.
One case involved a 40-year-old male who involved in an act of violence. The T/E ratio was 31.2, and STAN was detected in the urine sample together with the two metabolites [16-hydroxystanozolol (16STAN) and 3 0 -hydroxystanozolol (3STAN)]. The semi-quantitative method estimated the concentrations to be 150, 100 and .2,000 ng/mL for STAN, 16STAN and 3STAN, respectively. The male subject had been beaten by a baseball bat and stabbed with a knife and had therefore been hospitalized and had received analgesics, which were seen in additional analyses.
A second case involved a young male aged 22 years suspected of being a sex offender. ND and two metabolites 19NAN and 19NET were detected with estimated concentrations of 200, .3,000 and 600 ng/mL, respectively. A T/E ratio of 30.5 was also found together with TREN and 17TREN at concentrations of 100 and 53 ng/mL, respectively. In additional analyses performed in blood, tetrahydrocannabinol was found in a concentration of 3 ng/mL and benzoylecgonine at 100 ng/mL. Ethanol was present in the urine sample in a concentration of 0.44 g/kg.
Discussion
Determination of T/E ratio
The simple method for determining the T/E ratio using peak areas was the least comprehensive of the methods applied, and in contrast to the SIL-IS method, it does not account for any suppression of the signal or variation during sample preparation. Student's t-test revealed that the area ratio approach gave lower values of the T/E ratio compared with the SIL-IS method. However, comparison of the two procedures gave a relatively narrow confidence interval and the simple approach based on peak areas proved to be valid as a screening method, taking this inaccuracy into account. Samples with a T/E ratio above a set threshold in a screening method using only the raw peak areas should be further investigated using the method including SIL-IS. This outcome suggests that a fairly low threshold should be set in the screening method to avoid false negatives. As an alternative, more endogenous compounds could be included to provide a full steroid profile (30, 31) .
As of January 2014, WADA requires purified b-glucuronidase from Escherichia coli and does not accept b-glucuronidase/ arylsulfatase from H. pomatia for enzymatic preparation of urine samples for steroid analysis (32) . Enzymatic treatment with H. pomatia can produce artifacts by converting endogenous androst-5-ene-3b,17b-diol into T, thus leading to a slightly distorted T/E ratio (33, 34) . However, the use of sodium ascorbate has been shown to diminish the issues associated with H. pomatia (35) .
Detection of exogenous compounds
According to recent developments, common anabolic steroids can be measured by LC-MS-MS (4, 12, 15) . In case of poor ionization for some compounds, adduct formation may make detection possible (14) . The use of adduct ions was necessary for the boldenone metabolite (BOLD DH) and the mesterolone metabolite (MESTm) to obtain the desired selectivity and sensitivity. Even though all anabolic steroids may not be detected by LC -MS-MS with sufficient sensitivity to meet WADA requirements, commonly occurring anabolic steroids can be detected in concentrations usually observed in forensic cases (Table IV) (20, 36) . When analyzing the samples spiked at multiple levels with exogenous AAS, the identification criteria established by Rivier (25) were followed and included retention time, S/N ratio and ion ratio. The main reason that compounds did not fulfill the identification criteria at low concentrations was the lack of compliance of the ion ratios with the established limits. This discrepancy was mainly caused by high levels of background noise in some samples. Concerning specificity, one should be careful when selecting m/z values. Thorough examination of background signals in blank urines is necessary in at least 20 samples. We observed interference for several m/z values presented in the literature, making use of alternative values necessary. For OXA, a product ion of m/z: 229 was initially tested but endogenous interference was observed (37) , and product ions of m/z: 289 and 135 were used instead (38) . Thus, the present method may be less sensitive for some compounds, but, on the other hand, a high degree of selectivity has been attained with a very low chance of false positives.
Determination of anabolic steroids in forensic cases by LC -MS-MS
The fully automated extraction system presented here was able to prepare samples that were ready for injection into 96-well plates, even including enzyme treatment, incubation, SPE, evaporation and reconstitution. The offline automated system is an ideal platform for sample preparations prior to LC -MS. However, this methodology requires expensive instrumentation and highly trained experts (39) . Avoiding a derivatization step in the sample preparation is one advantage of choosing LC-MS over GC-MS (40) , but it may also be practical to use this technique in a laboratory like ours, where the predominating instrumentation is LC -MS-MS. Recent developments in UHPLC systems have furthermore increased the sensitivity and decreased run times significantly, thereby supporting the LC approach (12) . Commercially available columns with sub-2 mm particles have enabled better and faster chromatographic separation, with UHPLC systems being able to handle the high pressures. This development has been particularly interesting when analyzing isobaric compounds and has led to a 5-to 10-fold increase in sensitivity (41, 42) . Furthermore, TOF MS and Orbitrap MS techniques have expanded the applications of LC-MS including analysis of alternative biological matrices found in forensic cases (43) . This includes hair analysis (44) and direct analysis of phase II metabolites of AAS using high-resolution mass spectrometry (45) .
In the forensic material, 17 of 580 (2.9%) samples were positive of AAS abuse. The samples included samples from both males and females and both postmortem and antemortem samples. A study of 500 both competitive and noncompetitive bodybuilders conducted by Parkinson et al. (46) suggests that 80% of the AAS users are young males aged between 18 and 35 years. When looking at samples from this demographic subgroup, 14 of 227 (5.7%) samples were positive. Thus, screening of this selected group could be preferred. However, the forensic material also involves samples from drug addicts using AAS, which tend to widen the age interval of the target group.
In the forensic material, only six different exogenous AAS were found. ND was the most predominant AAS, as it and/or its metabolites were found in 10 cases. The exogenous AAS were in high concentration, as 12 of 15 (80%) positive samples had a concentration above 100 ng/mL for one or more compounds. Six of 13 (46%) positive antemortem samples were directly linked to an act of violence not including sexual assault. The use of AAS is suggested to be related to heightened levels of violent behavior (47) , but it is uncertain whether AAS act as an immediate trigger for a violent act (36) . The observed T/E ratio for samples positive of T abuse ranged from 14.5 to 260 (mean: 59.7) also suggesting that the abusers in the forensic material do not try to conceal the abuse as opposed to a professional athlete subjected to doping control. These findings are in agreement with similar investigations (20, 48) , confirming that only a limited selection of compounds are being abused and that the concentrations of AAS in forensic cases generally are much higher than in cases concerning doping in sports.
Conclusion
A screening method for detection of AAS in urine using a fully automated sample preparation and LC-MS-MS has been presented and validated. The method analyzed for 18 exogenous AAS and also determined the ratio of the endogenous T and E. All actions during sample preparation were fully automated including incubation, centrifugation and SPE. The qualitative method for the exogenous compounds had a LLOI that ranged from 2 to 40 ng/mL. Selectivity was thoroughly tested and emphasized the need for at least 20 samples during validation when using LC-MS-MS for analyzing AAS. A total of 580 samples from forensic cases were analyzed, and 17 (2.6%) samples were found positive of AAS. Only six different exogenous AAS were observed, and in 80% of the positive cases the concentration of one or more AAS exceeded 100 ng/mL.
